(HealthDay News) — A wearable device may improve physical activity, physical function, dyspnea, and pain after lung cancer surgery, according to a study published in JAMA Network Open.
NextRNA Therapeutics, a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, today announced the appointment of Jesse Smith, Ph ...